Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Orlistat

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 578Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Divis Laboratories
    India
    		 Parmarine Co., Ltd. 20200707-209-J-679 Orlistat 2020-07-07 Divi's Laboratories Limited India Unit-2, Chippada Village Annnavaram Post Bheemunipatnam Mandal Visakhapatnam District - 531 162, Andhra Pradesh India
    28/09/2024 Divis Laboratories
    India
    		 Narsha Farm Co., Ltd. 20200707-209-J-679(1) Orlistat 2022-07-08 Divi's Laboratories Limited India Unit-2, Chippada Village Annnavaram Post Bheemunipatnam Mandal Visakhapatnam District - 531 162, Andhra Pradesh India